What is Rivus Pharmaceuticals worth?
$489.0Mlast known valuation
Rivus Pharmaceuticals last raised $57.0M in its Later Stage VC (Jan 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Rivus Pharmaceuticals
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2025 | Later Stage VC | $57.0M | ▮ | ▮ |
| Aug 2024 | Later Stage VC | $66.0M | ▮ | ▮ |
| Aug 2022 | Early Stage VC (Series B) | $132.0M | ▮ | ▮ |
| Mar 2019 | Early Stage VC | $34.5M | ▮ | ▮ |
How Rivus Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Rivus Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Rivus Pharmaceuticals worth?
- Rivus Pharmaceuticals's last known valuation is $489.0M.
- How much has Rivus Pharmaceuticals raised?
- Rivus Pharmaceuticals has raised $224.0M in total funding across 4 recorded rounds.
- When did Rivus Pharmaceuticals last raise?
- Rivus Pharmaceuticals last raised in Jan 2025 (Later Stage VC), raising $57.0M.